TY - JOUR
AU - Veereman, G.
AB - S160 Poster presentations (39.4%, P < 0.05), and DBE provides much more detailed Methods: Data from the BELCRO database were evaluated at descriptions of specific endoscopic features such as segmental diagnosis (M0), after 24 (M24) and 36 months (M36). Cross distribution and lumen changes. Forty patients were diagnosed sectional analysis at M36 and longitudinal analysis from M0 to as new CD thanks DBE (Table 2). M36 were performed on the outcome data obtained. Hypothesis were tested at 5% significance. Results: At M 36, consecutive data were available on 84 Table 2. Different indications and information of detecting CD patients. From the initial 65%, 56% remained under pediatric Aim of procedure No. of No. of Results care at M36 with an unchanged proportion (70%) at tertiary patients procedures care hospitals. Between time point M0 and M36, disease Suspecting CD 30 52 21 new CD Evaluate of known CD 22 30 9 new stricture, 11 expansion of involvement severity evolved from 5% inactive to 70%, from 19% mild Mid GI bleeding 210 250 12 new CD disease to 24% and from 76% moderate to severe disease to SB obstruction 26 36 4 new CD Suspicious GI malignancy 20 39 3 New 
TI - P236 Disease severity after 3 years of treating newly diagnosed pediatric Crohn's disease patients (the BELCRO cohort)
JF - Journal of Crohn's and Colitis
DO - 10.1016/S1873-9946(14)60357-3
DA - 2014-02-01
UR - https://www.deepdyve.com/lp/oxford-university-press/p236-disease-severity-after-3-years-of-treating-newly-diagnosed-j0NQAnr1xT
SP - S160
EP - S160
VL - 8
IS - Supplement_1
DP - DeepDyve
ER -